GE HealthCare and PT Kalbe Farma Tbk (Kalbe) have launched the first computed tomography (CT) scanner production facility in Indonesia, a significant step towards localising the production of medical devices and improving diagnostic services across the country.
This milestone was achieved through a strategic partnership between Kalbe’s subsidiary Forsta and GE HealthCare.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The facility, situated at PT Forsta Kalmedic Global in Bogor, is set to address the healthcare challenges faced by Indonesia’s population of more than 280 million.
By producing CT scanners domestically, Kalbe and GE HealthCare intend to minimise the country’s reliance on imports, shorten delivery times, and make crucial diagnostic tools more accessible to hospitals and clinics nationwide.
Kalbe president director Irawati Setiady said: “The strategic partnership between Kalbe and GE HealthCare to supply CT scan machines locally exemplifies Kalbe’s commitment to government efforts focused on supporting national health resilience and local health industry self-sufficiency.
“We hope that by producing the CT scan machines domestically will also enhance healthcare services and improving the quality of life for the Indonesian population.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataCT scanners are said to be key diagnostic tools, known for their precision in detecting several diseases.
The facility is expected to create employment opportunities and support the growth of the country’s health technology workforce while facilitating knowledge transfer in medical manufacturing.
GE HealthCare International president and CEO Elie Chaillot said: “This facility will help us respond faster to local needs while maintaining the highest international standards of quality and safety.
“This production facility improves access to critical advanced diagnostic technology, creates high-value jobs and supports the development of Indonesia’s health technology workforce.”
This May, GE HealthCare received 501(k) clearance from the US Food and Drug Administration for its CleaRecon DL technology, as well as a European CE Mark.
